Non-Squamous Non-Small Cell Lung Cancer Active Not Recruiting Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Non-squamous Non-small Cell Lung Cancer

IndicationStatusPhase
DBCOND0036730 (Non-Squamous Non-Small Cell Lung Cancer)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02366143A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Treatment
NCT01763671Paclitaxel-bevacizumab in Advanced Lung CancerTreatment